跳至主要内容
临床试验/ACTRN12621001109897
ACTRN12621001109897招募中未知

The effect of nocturnal supplemental oxygen for the management of obstructive sleep apnoea in patients with fibrotic interstitial lung disease

Dr Yet Hong Khor0 个研究点目标入组 54 人开始时间: 2021年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age greater than or equal to 18 years
  • 2.Able to give written informed consent
  • 3.A multidisciplinary diagnosis of fibrotic interstitial lung disease of any aetiology
  • 4.Suspected obstructive sleep apnoea or confirmed diagnosis of obstructive sleep apnoea using overnight polysomnography

排除标准

  • 1.Use of or eligible for long-term oxygen therapy
  • 2.Use of respiratory stimulants or depressants
  • 3.Stable health condition (defined as hospitalisation for acute medical conditions) in the last 4 weeks before screening
  • 4.Significant co-existing chronic obstructive pulmonary disease (defined as FEV1/FVC <60% on the most recent lung spirometry or extent of emphysema greater than extent of fibrosis on the most recent CT chest)

研究者

发起方
Dr Yet Hong Khor

相似试验